IGS Wins FDA Funds to Sequence Pathogens, Create Database for Use in New Dx Development | GenomeWeb

NEW YORK (GenomeWeb News) – The Institute for Genome Sciences at the University of Maryland School of Medicine has received a $1.4 million contract from the US Food and Drug Administration to sequence, assemble, and annotate a population of bacterial pathogens.

The goal of the two-year project is to generate draft sequence data that other researchers will be able to use to develop and assess new high-throughput sequencing-based in vitro diagnostics for identifying pathogens, the University of Maryland Medical Center said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.

In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."

In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.

Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.

Mar
30
Sponsored by
SeraCare

Our roundtable of industry experts will provide an overview of the current regulatory landscape for clinical genomics tests.

Apr
13
Sponsored by
SeraCare

In this webinar, Gregory J. Tsongalis of Dartmouth Hitchcock Medical Center will discuss how his lab developed and validated a cancer hotspot assay. 

Apr
27
Sponsored by
SeraCare

This webinar is the third in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.